UC-MSC-Derived Secretome

Biologic

UUniversitas Sriwijaya

UC-MSC-Derived Secretome is one of 23 biologic programs targeting Osteoarthritis. It is currently in development.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

OsteoarthritisActive, not recruiting

OsteoarthritisPhase 2/Phase 3

Active, not recruiting

Competition

Competitive Landscape

778 competitors in Osteoarthritis

#DrugCompanyPhaseTrials

Toradol

Roche

Preclinical

1 2

Cataflam

Platelet Rich Plasma

25 4

Voltaren

CCerimon Pharmaceuticals

Preclinical

4 5

Enbrel

IImmunex

Preclinical

2 6

MS Contin

HHikma Pharmaceuticals LLC

Preclinical

1 7

Protonix

WWyeth-Lederle Vaccines

Preclinical

1 8

Paracetamol

GSK

Preclinical

4 9

Naproxen Sodium

Bayer

Preclinical

1 10

Decadron

QQuince Therapeutics S.p.A.

Preclinical

—

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Timeline

Expected Milestones

Q2 2027

Phase 2/3Not yet recruiting

Osteoarthritis

NCT07337863

Clinical

Trials by Indication[1]

Osteoarthritis1 trial

A Phase II/III Randomized Double-Blind Multicenter Study Comparing UC-MSC-Derived Secretome and Sodium Hyaluronate in Patients With Knee Osteoarthritis

Not yet recruiting·UUniversitas Sriwijaya·Phase 2/3·NCT07337863·50 enrolled

Sources

References

[1]
ClinicalTrials.gov — 1 trial record for UC-MSC-Derived Secretome. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — UC-MSC-Derived Secretome compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for UC-MSC-Derived Secretome. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — Universitas Sriwijaya company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Biologic[2]
Company: UUniversitas Sriwijaya

UC-MSC-Derived Secretome

Status by Indication[3][1]

Competitive Landscape

Expected Milestones

Q2 2027

Trials by Indication[1]

Osteoarthritis1 trial

References

Drug Info

Quick Facts

Related News